Commonwealth Bank of Australia’s AstraZeneca AZN Stock Holding History

Commonwealth Bank of Australia’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-10,326	Closed	-$670K	–	809
2014 Q1	$670K	Buy	10,326 +5,726	+124%	+$370K	﹤0.01%	942
2013 Q4	$273K	Sell	4,600 -100	-2%	-$5.43K	﹤0.01%	1141
2013 Q3	$244K	Buy	4,700 +100	+2%	+$5.02K	﹤0.01%	1128
2013 Q2	$218K	Buy	+4,600	New	+$234K	﹤0.01%	1089

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Commonwealth Bank of Australia's AZN Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of AstraZeneca (AZN) in Q2 2014, closing a stake of 10,326 shares — an estimated $670K sold.

Commonwealth Bank of Australia first reported a position in AZN in Q2 2013 and held it in 4 quarters. The position peaked at $670K in Q1 2014. 419 funds tracked by Wall St. Rank hold AZN as of Q2 2014.

Commonwealth Bank of Australia reported no remaining AstraZeneca position as of Q2 2014 after selling out during the quarter.
Commonwealth Bank of Australia sold 10,326 AstraZeneca shares in Q2 2014, an estimated $670K.
Commonwealth Bank of Australia first reported a position in AstraZeneca in Q2 2013 and held it in 4 quarters.
Commonwealth Bank of Australia's AstraZeneca position peaked at $670K in Q1 2014.
419 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.